Skip to main content
Timothy Graubert, MD, Oncology, Boston, MA

TimothyAGraubertMD

Oncology Boston, MA

Hematologic Oncology

Professor of Medicine, Harvard Medical School

Dr. Graubert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Graubert's full profile

Already have an account?

  • Office

    55 Fruit Street
    Boston, MA 02114

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1997
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1988 - 1991
  • Harvard Medical School
    Harvard Medical SchoolClass of 1988

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2026
  • MO State Medical License
    MO State Medical License 1997 - 2014
  • CT State Medical License
    CT State Medical License 1990 - 1994
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndrome
    Timothy Graubert, MD, Clinical Cancer Research, Orlando, FL, 12/8/2019

Press Mentions

  • Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDS
    Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDSSeptember 16th, 2019
  • $11.5 Million Supports Innovation in Leukemia Research
    $11.5 Million Supports Innovation in Leukemia ResearchNovember 6th, 2018
  • Expert Point of View: Robert Hromas, MD
    Expert Point of View: Robert Hromas, MDJanuary 26th, 2016
  • Join now to see all

Grant Support

  • Genomics Of Treatment -Related Acute Myelogenous Leukemia: Susceptibility FactorsNational Cancer Institute2008–2012
  • High Speed Cell Sorter CoreNational Cancer Institute2010–2011
  • Whole Genome Sequencing Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2009–2010
  • Genomics Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2005–2008
  • Core--High Speed Cell Sorter FacilityNational Cancer Institute2004–2008
  • Acquistion Of An Influx GMP Cell Sorter: Infectious DiseaseNational Center For Research Resources2005
  • Acquistion Of An Influx GMP Cell Sorter: ImmunologyNational Center For Research Resources2005
  • Acquistion Of An Influx GMP Cell Sorter: Adult Human Stem CellsNational Center For Research Resources2005
  • Acquistion Of An Influx GMP Cell Sorter.National Center For Research Resources2005
  • Genetic Targeting Of Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1998–2002
  • Acquistion Of A Cytomation Moflo Cell SorterNational Center For Research Resources2001